| Literature DB >> 31703645 |
Guesh Gebremariam1,2, Haftom Legese3, Yemane Woldu4, Tadele Araya4, Kiflom Hagos4, Araya GebreyesusWasihun4.
Abstract
BACKGROUND: Bacterial infection of the urinary tract is among the common reasons for seeking medical attention in the community. Rapidly increasing antibiotic resistance of uropathogens is resulting in limited treatment options. Therefore, knowledge of the current uropathogens and their antibiotic susceptibility is important for better treatment of urinary tract infection.Entities:
Keywords: Antibiotic susceptibility; Bacteriological profile; Ethiopia; Mekelle University; Urinary tract infection
Mesh:
Substances:
Year: 2019 PMID: 31703645 PMCID: PMC6842233 DOI: 10.1186/s12879-019-4610-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Socio-demographic characteristics of the Study Participants with Symptomatic UTI ((N = 341) at Mekelle University, northern Ethiopia, February–September 2017
| Variables | Frequency | Percent (%) |
|---|---|---|
| Sex | ||
| Male | 97 | 28.4 |
| Female | 244 | 71.6 |
| Age (in years) | ||
| 16–19 | 29 | 8.5 |
| 21–25 | 217 | 63.6 |
| 26–30 | 90 | 26.4 |
| 31–35 | 5 | 1.5 |
| Stay at Mekelle University (in years) | ||
| 1st | 60 | 17.6 |
| 2nd | 77 | 22.6 |
| 3rd | 91 | 26.7 |
| 4th | 73 | 21.4 |
| 5th and above | 40 | 11.7 |
| Residence (Campuses) | ||
| Arid (Main Campus) | 206 | 60.4 |
| Adi Haqi | 89 | 26.1 |
| Ayder | 34 | 9.9 |
| Aynalam | 6 | 1.8 |
| Kalamino | 6 | 1.8 |
Prevalence of UTI with Regard to the Socio-Demographic Characteristics among Mekelle UniversityStudents with Symptomatic UTI, northern Ethiopia, February–September 2017
| Variables | Significant Bacteriuria | Percentage | Total | |
|---|---|---|---|---|
| Yes (%) | No (%) | |||
| Sex | ||||
| Male | 8(8.2) | 89(91.8) | 28.4 | 97 |
| Female | 64(26.2) | 180(73.8) | 71.6 | 244 |
| Age (in years) | ||||
| 16–20 | 5(17.2) | 24(82.8) | 8.5 | 29 |
| 21–25 | 46(21.2) | 171(78.8) | 63.6 | 217 |
| 26–30 | 21(23.3) | 69(76.7) | 26.4 | 90 |
| 31–35 | 0(0.0) | 5(100.0) | 1.5 | 5 |
| Residence (Campuses) | ||||
| Arid (Main Campus) | 39(19) | 167(81) | 60.4 | 206 |
| Adi Haqi | 21(23.4) | 68 | 26.1 | 89 |
| Ayder | 11(32.4 | 23(67.6) | 9.9 | 34 |
| Aynalam | 0(0.0) | 6(100) | 1.8 | 6 |
| Kalamino | 1(16.7) | 5(83.3) | 1.8 | 6 |
Fig. 1Frequency of bacterial uropathogen isolates among Mekelle University Studentswith symptomatic UTI, northern Ethiopia, February–September 2017
Antimicrobial Susceptibility Pattern of Gram Negative Bacterial Isolates among Mekelle University Students with Symptomatic UTI, northern Ethiopia, February–September 2017
| Bacterial Isolates(n) | Antibiotics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMC | CTR | NX | GEN | NA | NIT | CIP | COT | TE | C | ||
| S | 0(0.0) | 2(5.6) | 29(80.6) | 30(83.3) | 25(69.5) | 15(41.7) | 29(80.6) | 30(83.3) | 11(30.6) | 21(58.3) | 29(80.6) | |
| I | 3(8.3) | 3(8.3) | 0(0.0) | 2(5.6) | 8(22.2) | 5(13.9) | 2(5.6) | 3(8.3) | 3(8.3) | 3(8.3) | 0(0.0) | |
| R | 33(91.7) | 31(86.1) | 7(19.4) | 4(11.1) | 3(8.3) | 16(44.4) | 5(13.8) | 3(8.3) | 22(61.1) | 12(33.3) | 7(19.4) | |
| S | 0(0.0) | 1(16.7) | 5(83.3) | 4(66.7) | 4(66.7) | 3(50.0) | 3(50.0) | 5(83.3) | 1(16.7) | 1(16.7) | 3(50.0) | |
| I | 1(16.7) | 1(16.7) | 0(0.0) | 1(16.7) | 0(0.0) | 1(16.7) | 0(0.0) | 1(16.7) | 1(16.7) | 2(33.3) | 2(33.3) | |
| R | 5(83.3) | 4(66.7) | 1(16.7) | 1(16.7) | 2(33.3) | 2(33.3) | 3(50.0) | 0(0.0) | 4(66.7) | 3(50.0) | 1(16.7) | |
| S | 0(0.0) | 0(0.0) | 2(100) | 1(50.0) | 2(100) | 1(50.0) | 2(100) | 2(100) | 1(50.0) | 1(50.0) | 2(100) | |
| I | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
| R | 2(100) | 1(50.0) | 0(0.0) | 1(50.0) | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 1(50.0) | 1(50.0) | 0(0.0) | |
| S | 0(0.0) | 0(0.0) | 2(100) | 2(100) | 1(50.0) | 1(50.0) | 2(100) | 2(100) | 0(0.0) | 1(50.0) | 1(50.0) | |
| I | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(50.0) | 0(0.0) | |
| R | 2(100) | 2(100) | 0(0.0) | 0(0.0) | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 2(100) | 0(0.0) | 1(50.0) | |
| S | 0(0.0) | 0(0.0) | 1(100) | 1(100) | 1(100) | 0(0.0) | 1(100) | 1(100) | 0(0.0) | 1(100) | 0(0.0) | |
| I | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(100) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(100) | |
| R | 1(100) | 1(100) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 1(0.0) | 0(0.0) | 0(0.0) | |
| Total | S | 0(0.0) | 3(6.4) | 39(83.0) | 38(80.8) | 33(70.2) | 20(42.6) | 37(78.7) | 40(85.1) | 13(27.7) | 25(53.1) | 35(74.5) |
| I | 4(8.5) | 5(10.7) | 0(0.0) | 3(6.4) | 9(19..2) | 7(14.8) | 2(4.3) | 4(8.5) | 4(8.5) | 6(12.8) | 3(6.4) | |
| R | 43(91.5) | 39(82.9) | 8(17.0) | 6(12.8) | 5(10.6) | 20(42.6) | 8(17.0) | 3(6.4) | 30(63.8) | 16(34.0) | 9(19.1) | |
Key; AMC Amoxacillin clavulanic acid, AMP Ampicillin, NA Nalidixic acid, NX Norfloxacilin, NIT Nitrofruinton, CTR Ceftriaxone, GEN Gentamicin, COT Co-trimexazole, TE Tetracycline, C Chloramphenicol, CIP Ciprofloxacin, S Susceptible, I Intermediate, R Resistant. % is computed from each cell. Total total resistance of gram negative isolates for the specific tested
Antimicrobial Susceptibility Patterns of Gram Positive Bacterial Isolates among Mekelle University Students with Symptomatic UTI, Northern Ethiopia, February–September 2017
| Bacterial isolate(n) | Antibiotics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMC | CTR | NX | GEN | NIT | CIP | COT | TE | ERY | C | ||
| S | 4(23.5) | 5(29.4) | 15(88.2) | 12(70.6) | 17(100) | 16(94.1) | 17(100) | 10(58.8) | 8(47.1) | 9(52.9) | 14(82.3) | |
| I | 1(5.9) | 1(5.9) | 1(5.9) | 2(11.8) | 0(0.0) | 1(5.9) | 0(0.0) | 1(5.9) | 6(35.3) | 2(11.8) | 1(5.9) | |
| R | 12(70.6) | 11(64.7) | 1(5.9) | 3(17.6) | 0(0.0) | 0(0.0) | 0(0.0) | 6(35.3) | 3(17.6) | 6(35.3) | 2(11.8) | |
| S | 1(10.0) | 1(10.0) | 6(60.0) | 7(70.0) | 6(60.0) | 6(60.0) | 7(70.0) | 2(20.0) | 4(40.0) | 5(50.0) | 4(80.0) | |
| I | 0(0.0) | 1(10.0) | 1(10.0) | 0(0.0) | 1(10.0) | 0(0.0) | 0(0.0) | 1(10.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
| R | 9(90.0) | 8(80.0) | 3(30.0) | 3(30.0) | 3(30.0) | 4(40.0) | 3(30.0) | 7(70.0) | 6(60.0)c | 5(50.0) | 6(60.0) | |
| Total | S | 5(18.5) | 6(22.2) | 21(77.8) | 19(70.4) | 23(85.2) | 22(81.5) | 24(88.9) | 12(44.4) | 12(44.4) | 14(51.9) | 18(66.6) |
| I | 1(3.7) | 2(7.4) | 2(7.4) | 2(7.4) | 1(3.7) | 1(3.7) | 0(0.0) | 2(7.4) | 6(22.2) | 2(7.4) | 1(3.7) | |
| R | 21(77.8) | 19(70.) | 4(14.8) | 6(22.2) | 3(11.1) | 4(14.8) | 3(11.1) | 13(48.2) | 9(33.3) | 11(40.7) | 8(29.6) | |
Key; AMC Amoxacillin clavulanic acid, AMP Ampicillin, NX Norfloxacilin, NIT Nitrofruinton, CTR Ceftriaxone, GEN Gentamicin, COT Co-trimexazole, TE Tetracycline, ERY Erythromycin, C Chloramphenicol, CIP Ciprofloxacin, S Susceptible, I Intermediate, R Resistant. % is computed from each cell, Total total resistance of gram positive isolates for the specific tested
Level of Antimicrobial Resistance of Uropathogen Bacterial Isolates among Mekelle University Students with Symptomatic UTI, Northern Ethiopia, February–September 2017
| Bacterial isolates(n) | Antibiotics | |||||||
|---|---|---|---|---|---|---|---|---|
| Ro (%) | R1 (%) | R2 (%) | R3 (%) | R4 (%) | MDR (%) | ESBL producers(%) | Total (%) | |
| Gram Negative | 1(2.1) | 1(2.1) | 5(10.6) | 20(42.6) | 20(42.6) | 41(87.2%) | 12(25.5) | 47(100) |
| 0(0.0) | 1(2.8) | 2(5.6) | 18(50) | 15(41.6) | 33 (88.9) | 10(27.8) | 36(100) | |
| 1(16.7) | 0(0.0) | 1(16.7) | 2(33.3) | 2(33.3) | 5(83.3) | 2(33.3) | 6(100) | |
| 0(0.0) | 0(0.0) | 1(50) | 0(0.0) | 1(50) | 1(50) | 0(0.0) | 2(100) | |
| 0(0.0) | 0(0.0) | 1(50) | 0(.00) | 1(50) | 1(50) | 0(0.0) | 2(100) | |
| 0(0.0) | 0(.00) | 0(.00) | 0(0.0) | 1(100) | 1(100) | 0(0.0) | 1(100) | |
| Gram positive | 5(18.5) | 4(14.8) | 4(18.5) | 8(29.6) | 6(18.5) | 13(48.1%) | NT | 27(100) |
| CoNS | 4(23.5) | 2(11.8) | 3(17.6) | 5(29.5) | 3(17.6) | 7(41.2) | NT | 17(100) |
| 1(10) | 2(20) | 1(10) | 3(30) | 3(30) | 6(60) | NT | 10(100) | |
| Total | 6(8.1) | 5 (6.8) | 9(12.2) | 28(37.8) | 26(35.1) | 54(73.0) | 12(25.5) | 74(100) |
Key;R0- susceptible to allantibiotics, R1- Resistance to one antibiotic, R2-Resistance to antibiotics, R3-Resistance to threeantibiotics, ≥ R4-resistance to four and above antibiotics, NT not test, MDR Multidrug resistant: non-susceptible to at least one agent in three antimicrobial categories [65]. Based on this definition, the following antimicrobial categories were considered to determine whether the given isolate is MDR Gram positive isolates and Enterobacteriacecae: aminoglycosides (gentamicin), cephems (ceftiraxone), pencillin (ampcillin), beta lactamase inhibitor combination (amoxicillin/clavulanic acid), fluoroquinolones (ciprofloxacin,norfloxacin), nitrofuran (nitrofurantoin), cotrimoxazole, tetracycline and phenicols (chloramphenicol). Of these, nalidixic acid and macrolides (erythromycin) was used only for enterobacteriacecae and Gram positive isolates
Risk factors associated with UTI among Mekelle University students with symptomatic UTI, northern Ethiopia, February–September 2017
| Variable | Total | Significant Bacteriuria | COR (95% CI) | AOR (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
| Yes (%) | No (%) | |||||||
| Sex | ||||||||
| Male | 97 | 8(8.2) | 89(91.8) | 1 | ||||
| Female | 244 | 64(26.2) | 180(73.8) | 3.96(2.45–14.02) | 0.001 | 7.42(1.25–43.96) | 0.027* | |
| Age (in years) | ||||||||
| 16–20 | 29 | 5(17.2) | 24(82.8) | 1 | ||||
| 21–25 | 217 | 46(21.2) | 171(78.8) | 1.29(0.242–3.26) | 0.752 | NA | ||
| 26–30 | 90 | 21(23.3) | 69(76.7) | 1.46(0.41–6.24) | 0.505 | NA | ||
| 31–35 | 5 | 0(0.0) | 5(100.0) | NA | ||||
| Current symptoms | ||||||||
| Dysuria | No | 91 | 9 | 82 | 1 | |||
| Yes | 250 | 63 | 187 | 3.06(1.263–5.632) | 0.010 | 3.38 (1.001–11.44 | 0.052 | |
| Frequency | No | 96 | 13 | 83 | 1 | |||
| Yes | 245 | 59 | 186 | 2.02(1.004–3.593) | 0.048 | 0.73 (0.279–1.93) | 0.534 | |
| Urgency | No | 110 | 14 | 103 | 1 | |||
| Yes | 231 | 58 | 173 | 2.46 (1.567–5.719) | 0.001 | 1.605(.637–4.046) | 0.316 | |
| Hematuria | No | 290 | 51 | 239 | 1 | |||
| Yes | 51 | 21 | 30 | 3.28 (1.370–6.34) | 0.006 | 0.812(0.26–2.58) | 0.725 | |
| Abdominal pain | No | 80 | 13 | 67 | 1 | |||
| Yes | 261 | 59 | 202 | 1.50(.813–3.040) | 0.179 | NA | ||
| Fever | No | 147 | 30 | 117 | 1 | |||
| Yes | 194 | 42 | 152 | 1.07 (.633–1.795) | 0.811 | NA | ||
| Flank pain | No | 248 | 39 | 209 | 1 | |||
| Yes | 93 | 33 | 60 | 2.95 (2.12–10.955) | 0.001 | 3.776(1.552–9.18) | 0.003* | |
| Urinary Incontinence | No | 215 | 29 | 186 | 1 | |||
| Yes | 126 | 43 | 83 | 3.32 (3.007–9.116) | 0.001 | 2.07 (0.855–4.99) | 0.107 | |
Association of Other Enabling Factors with UTI among Mekelle University Students with Symptomatic UTI, Northern Ethiopia, February–September 2017
| Variable | Total | Significant Bacteriuria | COR (95%,CI) | AOR (95%,CI) | |||
|---|---|---|---|---|---|---|---|
| Yes | No | ||||||
| History of UTI | |||||||
| No | 299 | 46 | 253 | 1 | |||
| Yes | 42 | 26 | 16 | 8.93 (5.27–28.14) | 0.001 | 5.75 (1.70–19.4) | 0.005* |
| History of DM | |||||||
| No | 316 | 66 | 250 | 1 | |||
| Yes | 15 | 6 | 9 | 2.52 (.130–12.411) | 0.836 | NA | |
| Using contraceptive | |||||||
| No | 313 | 60 | 253 | 1 | |||
| Yes | 28 | 12 | 16 | 3.16(2.30–8.427) | 0.001 | 1.14(0.412–3.17) | 0.798 |
| History of Medication | |||||||
| No | 297 | 57 | 240 | 1 | |||
| Yes | 44 | 15 | 29 | 2.17(1.53–14.46) | 0.001 | 1.98(0.422–9.27) | 0.386 |
| History of Catheter | |||||||
| No | 330 | 66 | 264 | 1 | |||
| Yes | 11 | 6 | 5 | 4.8 (1.68–22.387) | 0.006 | 18.2 (4.45–74.77) | 0.001* |
| Male Circumcision | |||||||
| No | 19 | 3 | 16 | 2.73 (2.120–14.063) | 0.001 | 3.89(0.66–71.56) | 0.106 |
| Yes | 78 | 5 | 73 | 1 | |||
| Female Sexual Activity | |||||||
| Never had Sex | 177 | 43 | 134 | 1 | |||
| Had sex < 3 per week | 61 | 16 | 45 | 1.1(1.004–3.593) | 0.048 | 1.605(0.637–4.05) | 0.316 |
| Had sex ≥3 per week | 11 | 5 | 6 | 2.59 (1.26–6.12) | 0.015 | 2.16 (1.149–3.69) | 0.012* |
Note: *Statistically significant at P < 0.05.DM, diabetes mellitus; AOR adjusted odds ratio, COR crude odds ratio, 1 referent group, CI confidence interval, N/A not applicable